# KALA BIO, Inc. (KALA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/KALA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -3.20M | $ -4.43M | $ 0 | $ 9.04M |
| 2025 | $ 0 | $ -27.63M | $ -32.76M | $ 0 | $ 7.00M |
| 2024 | $ 0 | $ -40.48M | $ -30.96M | $ 32.25M | $ 12.33M |
| 2023 | $ 0 | $ -45.63M | $ -30.86M | $ 36.32M | $ 7.50M |
| 2022 | $ 4.35M | $ -50.07M | $ -88.50M | $ 42.95M | $ 18.97M |
| 2021 | $ 13.36M | $ -169.51M | $ -129.71M | $ 80.19M | $ 16.80M |
| 2020 | $ 8.10M | $ -132.91M | $ -118.01M | $ 100.92M | $ 100.00M |
| 2019 | $ 7.84M | $ -121.78M | $ -121.40M | $ 101.18M | $ 29.69M |
| 2018 | $ 0 | $ -88.14M | $ -73.56M | $ 99.44M | $ 104.99M |
| 2017 | $ 0 | $ -56.86M | $ -46.58M | $ 18.65M | $ 89.68M |
| 2016 | $ 0 | $ -45.63M | $ -37.84M | $ 9.65M | $ -87.76M |
| 2015 | $ 0 | $ -6.90M | $ -5.09M | $ 9.80M | $ -5.79M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.17 |
| Current Ratio | 6.88 |

## Other views

- [Metrics](https://sponda.capital/en/KALA.md)
- [Charts](https://sponda.capital/en/KALA/charts.md)
- [Compare](https://sponda.capital/en/KALA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.